UnitedHealth Group Incorporated (NYSE:UNH) Receives $366.52 Consensus PT from Brokerages

Shares of UnitedHealth Group Incorporated (NYSE:UNH) have earned a consensus rating of “Moderate Buy” from the twenty-four ratings firms that are presently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a sell rating, six have issued a hold rating and fifteen have issued a buy rating on the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $366.5238.

A number of equities research analysts have commented on the company. Hsbc Global Res lowered UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research report on Wednesday, May 21st. Truist Financial cut their price target on UnitedHealth Group from $360.00 to $345.00 and set a “buy” rating for the company in a research note on Wednesday, July 16th. UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Baird R W downgraded UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Finally, Erste Group Bank downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 30th.

UnitedHealth Group Trading Up 12.0%

NYSE:UNH opened at $304.02 on Thursday. UnitedHealth Group has a 1-year low of $234.60 and a 1-year high of $630.73. The firm has a market capitalization of $275.34 billion, a price-to-earnings ratio of 13.17, a price-to-earnings-growth ratio of 1.96 and a beta of 0.43. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a fifty day simple moving average of $288.91 and a 200 day simple moving average of $396.85.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the business posted $6.80 earnings per share. The company’s revenue was up 12.9% compared to the same quarter last year. Sell-side analysts forecast that UnitedHealth Group will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares of the company’s stock, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.28% of the company’s stock.

Institutional Trading of UnitedHealth Group

Several institutional investors have recently modified their holdings of the company. Parr Mcknight Wealth Management Group LLC boosted its stake in UnitedHealth Group by 24.1% in the 2nd quarter. Parr Mcknight Wealth Management Group LLC now owns 25,772 shares of the healthcare conglomerate’s stock valued at $8,040,000 after buying an additional 5,004 shares in the last quarter. Headlands Technologies LLC acquired a new stake in UnitedHealth Group in the 2nd quarter valued at $511,000. CANADA LIFE ASSURANCE Co boosted its stake in UnitedHealth Group by 7.1% in the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 1,189,542 shares of the healthcare conglomerate’s stock valued at $371,503,000 after buying an additional 79,311 shares in the last quarter. 44 Wealth Management LLC boosted its stake in UnitedHealth Group by 41.7% in the 2nd quarter. 44 Wealth Management LLC now owns 2,140 shares of the healthcare conglomerate’s stock valued at $668,000 after buying an additional 630 shares in the last quarter. Finally, Tower Research Capital LLC TRC boosted its stake in UnitedHealth Group by 25.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 51,501 shares of the healthcare conglomerate’s stock valued at $16,067,000 after buying an additional 10,291 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.